These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 2431456)
1. [Calcium and contraction of the myocardial cell]. Antony I; Nitenberg A Rev Prat; 1986 Oct; 36(43):2481-7. PubMed ID: 2431456 [No Abstract] [Full Text] [Related]
2. Calcium flux regulation in myocardial and vascular smooth muscle. Moura AM; Hamon G; Worcel M Adv Nephrol Necker Hosp; 1985; 14():173-96. PubMed ID: 2579534 [No Abstract] [Full Text] [Related]
3. Calcium antagonism: a new approach. Nayler WG Clin Exp Pharmacol Physiol Suppl; 1982; 6():3-13. PubMed ID: 6288293 [TBL] [Abstract][Full Text] [Related]
4. [Research on a new type of cardiotonic agents with calcium-sensitizing activity]. Ling Y Sheng Li Ke Xue Jin Zhan; 1992 Jan; 23(1):41-5. PubMed ID: 1329193 [No Abstract] [Full Text] [Related]
5. [Evaluation of the effect of cardiotropic agents using a mathematical model of electromechanical coupling]. Pratusevich VR; Zykov VS; Mukumov MR Biofizika; 1987; 32(4):668-72. PubMed ID: 2444267 [TBL] [Abstract][Full Text] [Related]
11. [Contraction-relaxation cycle in the heart]. Verbolovich VP; Esyrev OV Usp Sovrem Biol; 1981; 91(2):269-76. PubMed ID: 6264703 [No Abstract] [Full Text] [Related]
12. [Mitochondrial participation in regulating the transmembrane Ca2+ current within myocardial cells]. AlabovskiÄ VV; Kobrin VI Usp Fiziol Nauk; 1985; 16(1):3-20. PubMed ID: 2579514 [No Abstract] [Full Text] [Related]
13. Regulation of myocardial function in the normal and diseased heart. Modification by inotropic drugs. Katz AM; Smith VE Eur Heart J; 1982 Dec; 3 Suppl D():11-8. PubMed ID: 6218992 [No Abstract] [Full Text] [Related]
14. Hemodynamic effects of calcium-sensitizing agents. Vegh A; Papp JG; Udvary E; Kaszala K J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128 [TBL] [Abstract][Full Text] [Related]
15. [Calcium sensitizers--a new group of drugs that increase myocardium contractility]. Laine M; Lehtonen L; Nieminen MS Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622 [No Abstract] [Full Text] [Related]
16. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection. Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901 [TBL] [Abstract][Full Text] [Related]
17. [Calcium antagonists in the treatment of cardiovascular diseases (review of the literature)]. Chekman IS; Nizhenkovskaia IV Vrach Delo; 1982 Sep; (9):47-52. PubMed ID: 6294997 [No Abstract] [Full Text] [Related]
18. [Effect of hypoxia and fenigidin on the action potential duration and the strength of myocardial contraction in frogs]. Gendvilene VI; Narushevichus EV Biull Eksp Biol Med; 1981 Apr; 91(4):403-4. PubMed ID: 6266546 [TBL] [Abstract][Full Text] [Related]
19. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics. Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130 [TBL] [Abstract][Full Text] [Related]
20. [Effect of antioxidant histochrome preparation on the contractile function and metabolism of the isolated rat heart under conditions of "calcium paradox", ischemia, and reperfusion]. Vinokurov AA; AlabovskiÄ VV; Shul'zhenko VS; Ivanova MV; Lebedev AV Vopr Med Khim; 2001; 47(5):483-90. PubMed ID: 11766258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]